Cargando…
Multi-Targeting Approach in Selection of Potential Molecule for COVID-19 Treatment
The coronavirus disease (COVID-19) is a pandemic that started in the City of Wuhan, Hubei Province, China, caused by the spread of coronavirus (SARS-CoV-2). Drug discovery teams around the globe are in a race to develop a medicine for its management. It takes time for a novel molecule to enter the m...
Autores principales: | Velagacherla, Varalakshmi, Suresh, Akhil, Mehta, Chetan Hasmukh, Nayak, Usha Y., Nayak, Yogendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861341/ https://www.ncbi.nlm.nih.gov/pubmed/36680253 http://dx.doi.org/10.3390/v15010213 |
Ejemplares similares
-
Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study
por: Baby, Krishnaprasad, et al.
Publicado: (2021) -
Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An
in silico drug repurposing for COVID-19
por: Baby, Krishnaprasad, et al.
Publicado: (2020) -
SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study
por: Baby, Krishnaprasad, et al.
Publicado: (2021) -
Polyphenol-based targeted therapy for oral submucous fibrosis
por: Mehta, Chetan Hasmukh, et al.
Publicado: (2023) -
Comparative Evaluation of the Effectiveness of a Combination of Absorbable Gelatin Sponge and Calendula officinalis with Absorbable Gelatin Sponge Used Alone as a Hemostatic Agent—An In-Vitro Study
por: Ayyanahalli Matta, Bharath Kumar, et al.
Publicado: (2022)